• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Unsupervised online yoga transiently improves symptoms in patients with knee osteoarthritis

byAndrew LeeandKiera Liblik
September 27, 2022
in Chronic Disease, Orthopedic Surgery, Rheumatology
Reading Time: 3 mins read
Placebo formulation impacts effectiveness of pain control in osteoarthritis
Share on FacebookShare on Twitter

1. Compared to a control group, patients with knee osteoarthritis who engaged in online yoga had improvements in pain and function at 12 weeks of follow-up.

2. Improvements in pain and function in the online yoga group were not maintained at 24 weeks.

Evidence Rating Level: 2 (Good)

Study Rundown: Knee osteoarthritis is a significant source of disability as a result of pain, reduced function, and disruption of mood. There is a gap in the literature as to the impact of low-impact exercise on disease burden in knee osteoarthritis patients. Accordingly, the present study examined the effectiveness of an unsupervised online yoga program as compared to a control group in improving outcomes for patients with symptomatic knee osteoarthritis. The majority of patients in the treatment group adhered to the program to an acceptable level. Compared to the control population, the yoga group had greater improvements in function at 12 weeks. Minimal differences were observed in knee pain between groups at 12 weeks. The benefits of the yoga intervention were not maintained at the 24-week mark. Improvements in secondary outcomes such as stiffness, quality of life, arthritis self-efficacy for pain, and self-efficacy in other symptoms were improved at 12 weeks but not at 24 weeks. Factors such as age, gender, body mass index, the expectation of treatment effects, pain self-efficacy, and fear of movement did not significantly affect the relationship between yoga and primary outcomes at 12 weeks. No serious adverse events were reported throughout the study duration. However, due to reported difficulties with adherence and self-report measures, it is difficult to gauge the efficacy of the intervention in the general osteoarthritis population.

Click to read the study in AIM

Relevant Reading: Stepped exercise program for patients with knee osteoarthritis

RELATED REPORTS

Continuous femoral nerve block is not superior to continuous adductor canal block for postoperative pain following ACL reconstruction

2 Minute Medicine Rewind Aug 24th, 2026 

Joint fusion superior to watchful waiting for hallux rigidus 

In-Depth [randomized controlled trial]: This randomized control trial evaluated the effectiveness of an unsupervised 12-week online yoga program in patients with knee osteoarthritis compared to a control of only online education. The treatment group was provided access to an online website with 12 different prerecorded 30-minute videos, to be performed three times a week. The primary outcomes were 12-week changes in validated pain and physical function scales for knee osteoarthritis. A total of 212 participants were enrolled, with baseline characteristics that were acceptably similar between groups. Both primary outcomes were provided by 92% of participants at 12 weeks and 89% at 24 weeks, with minor differences between those who did and did not provide outcomes. Yoga group participants accessed the website a mean of 20.5 times (Standard deviation [SD], 19.5) for a mean of 25.4 minutes (SD, 12.8) per session over 12 weeks. Control participants accessed their online information for a mean of 1.6 times (SD, 1.5) for a mean of 9.8 minutes (SD, 14.3) during the first 12 weeks. The treatment group had greater improvements in function at 12 weeks (between-group mean difference in change, -4.0; 95% Confidence Interval [CI], -6.8 to -1.3). Only small differences were seen for knee pain during walking at 12 weeks (mean difference in change, -0.6; 95% CI, 1.09 to 1.91). Benefits seen in the primary outcomes did not persist at 24 weeks. At 12 weeks, yoga led to improvements in knee stiffness (mean difference in change, -0.4; 95% CI, -0.8 to 0.0), quality of life (mean difference in change, 0.04; 95% CI, 0.0 to 0.07), arthritis self-efficacy for pain (mean difference in change, 0.6; 95% CI, 0.1 to 1.1), and self-efficacy for other symptoms (mean difference in change, 0.6; 95% CI, 0.2 to 1.0). In summary, this study found that online yoga was not associated with long-term symptom improvement in knee osteoarthritis patients.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: arthritischronic diseaseknee arthritisknee osteoarthritislow-impact exerciseonline yogaorthopedic surgeryosteoarthritisrheumatologyyoga
Previous Post

#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma

Next Post

Dupilumab plus topical corticosteroids are effective in the treatment of childhood atopic dermatitis

RelatedReports

Social networks play key roles in parental vaccination decisions
Imaging and Intervention

Continuous femoral nerve block is not superior to continuous adductor canal block for postoperative pain following ACL reconstruction

September 7, 2026
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Lower target oxygen saturation in extremely preterm infants appears safe
Chronic Disease

The addition of leflunomide (Arava) to prednisone (Deltasone) may not improve rate of remission in Takayasu arteritis

July 10, 2026
Next Post
Pimecrolimus effective first-line treatment for atopic dermatitis

Dupilumab plus topical corticosteroids are effective in the treatment of childhood atopic dermatitis

Being overweight and obese associated with increased incidence of chronic kidney disease

Empagliflozin use associated with decreased rate of macroalbuminuria

#VisualAbstract: Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients

#VisualAbstract: Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Brepocitinib becomes first oral therapy approved for adult dermatomyositis
  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.